126 related articles for article (PubMed ID: 30445024)
1. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.
Anckaerts C; Blockx I; Summer P; Michael J; Hamaide J; Kreutzer C; Boutin H; Couillard-Després S; Verhoye M; Van der Linden A
Neurobiol Dis; 2019 Apr; 124():93-107. PubMed ID: 30445024
[TBL] [Abstract][Full Text] [Related]
2. Early brain connectivity alterations and cognitive impairment in a rat model of Alzheimer's disease.
Muñoz-Moreno E; Tudela R; López-Gil X; Soria G
Alzheimers Res Ther; 2018 Feb; 10(1):16. PubMed ID: 29415770
[TBL] [Abstract][Full Text] [Related]
3. Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer's rats.
Chaudry O; Ndukwe K; Xie L; Figueiredo-Pereira M; Serrano P; Rockwell P
Sci Rep; 2022 Nov; 12(1):19129. PubMed ID: 36352024
[TBL] [Abstract][Full Text] [Related]
4. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
[TBL] [Abstract][Full Text] [Related]
5. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
[TBL] [Abstract][Full Text] [Related]
6. Early ultrasonic vocalization deficits and related thyroarytenoid muscle pathology in the transgenic TgF344-AD rat model of Alzheimer's disease.
Rudisch DM; Krasko MN; Barnett DGS; Mueller KD; Russell JA; Connor NP; Ciucci MR
Front Behav Neurosci; 2023; 17():1294648. PubMed ID: 38322496
[TBL] [Abstract][Full Text] [Related]
7. Early altered directionality of resting brain network state transitions in the TgF344-AD rat model of Alzheimer's disease.
De Waegenaere S; van den Berg M; Keliris GA; Adhikari MH; Verhoye M
Front Hum Neurosci; 2024; 18():1379923. PubMed ID: 38646161
[TBL] [Abstract][Full Text] [Related]
8. Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer's disease.
Pentkowski NS; Berkowitz LE; Thompson SM; Drake EN; Olguin CR; Clark BJ
Neurobiol Aging; 2018 Jan; 61():169-176. PubMed ID: 29107184
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal characterization of cerebral hemodynamics in the TgF344-AD rat model of Alzheimer's disease.
Fang X; Tang C; Zhang H; Border JJ; Liu Y; Shin SM; Yu H; Roman RJ; Fan F
Geroscience; 2023 Jun; 45(3):1471-1490. PubMed ID: 36933144
[TBL] [Abstract][Full Text] [Related]
10. Resting State Networks in the TgF344-AD Rat Model of Alzheimer's Disease Are Altered From Early Stages.
Tudela R; Muñoz-Moreno E; Sala-Llonch R; López-Gil X; Soria G
Front Aging Neurosci; 2019; 11():213. PubMed ID: 31440158
[TBL] [Abstract][Full Text] [Related]
11. Secondary prevention of Alzheimer's dementia: neuroimaging contributions.
Ten Kate M; Ingala S; Schwarz AJ; Fox NC; Chételat G; van Berckel BNM; Ewers M; Foley C; Gispert JD; Hill D; Irizarry MC; Lammertsma AA; Molinuevo JL; Ritchie C; Scheltens P; Schmidt ME; Visser PJ; Waldman A; Wardlaw J; Haller S; Barkhof F
Alzheimers Res Ther; 2018 Oct; 10(1):112. PubMed ID: 30376881
[TBL] [Abstract][Full Text] [Related]
12. Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.
Joo IL; Lai AY; Bazzigaluppi P; Koletar MM; Dorr A; Brown ME; Thomason LA; Sled JG; McLaurin J; Stefanovic B
Sci Rep; 2017 Apr; 7():46427. PubMed ID: 28401931
[TBL] [Abstract][Full Text] [Related]
13. Sexual dimorphism in the peripheral metabolic homeostasis and behavior in the TgF344-AD rat model of Alzheimer's disease.
Srivastava H; Lasher AT; Nagarajan A; Sun LY
Aging Cell; 2023 Jul; 22(7):e13854. PubMed ID: 37095621
[TBL] [Abstract][Full Text] [Related]
14. Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer's model.
Wallace CH; Oliveros G; Serrano PA; Rockwell P; Xie L; Figueiredo-Pereira M
Life Sci Alliance; 2022 Sep; 5(12):. PubMed ID: 36167438
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor RG2833 has therapeutic potential for Alzheimer's disease in females.
Ndukwe K; Serrano PA; Rockwell P; Xie L; Figueiredo-Pereira M
bioRxiv; 2023 Dec; ():. PubMed ID: 38234827
[TBL] [Abstract][Full Text] [Related]
16. Obesity during preclinical Alzheimer's disease development exacerbates brain metabolic decline.
Anderson T; Sharma S; Kelberman MA; Ware C; Guo N; Qin Z; Weinshenker D; Parent MB
J Neurochem; 2024 May; 168(5):801-821. PubMed ID: 37391269
[TBL] [Abstract][Full Text] [Related]
17. Anxiety in Alzheimer's disease rats is independent of memory and impacted by genotype, age, sex, and exercise.
Lopez DC; White ZJ; Hall SE
Alzheimers Dement; 2024 May; 20(5):3543-3550. PubMed ID: 38624069
[TBL] [Abstract][Full Text] [Related]
18. Subject classification and cross-time prediction based on functional connectivity and white matter microstructure features in a rat model of Alzheimer's using machine learning.
Diao Y; Lanz B; Jelescu IO
Alzheimers Res Ther; 2023 Nov; 15(1):193. PubMed ID: 37936236
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
Kelberman MA; Rorabaugh JM; Anderson CR; Marriott A; DePuy SD; Rasmussen K; McCann KE; Weiss JM; Weinshenker D
Neurobiol Aging; 2023 May; 125():98-108. PubMed ID: 36889122
[TBL] [Abstract][Full Text] [Related]
20. Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
Stam CJ; de Haan W
J Alzheimers Dis; 2024; 99(4):1333-1348. PubMed ID: 38759000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
